Every client on tirzepatide needs a plan, but high-risk groups must execute a muscle-and-bone defense strategy from the first dose
In November and December 2025, the two largest clinical trials ever run with a glucagon-like peptide-1 receptor (GLP-1R) agonist in a neurodegenerative disease reported their results
Semaglutide acts on GLP-1 receptors in the brain, particularly in areas that regulate appetite and food intake, leading to reduced hunger and increased feelings of fullness
GLP-1s Are Tools, Not Cures First, its important to understand what these medications are meant to do
Finally, inspect the pen for any signs of damage
1H MRS measurement of cortical GABA and glutamate in primary insomnia and major depressive disorder: relationship to sleep quality and depression severity